Skip to main content
Top
Gepubliceerd in: Quality of Life Research 6/2007

01-08-2007 | Original Paper

Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes

Auteurs: Meryl Brod, Torsten Christensen, Donald Bushnell

Gepubliceerd in: Quality of Life Research | Uitgave 6/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Variables associated with treatment satisfaction (TS) can be broadly categorized as precursors, ongoing treatment issues, and treatment outcomes. This study continues the validation process for the Insulin Treatment Satisfaction Questionnaire (ITSQ) while examining relationships between TS and these broader influences.

Methods

Data (N = 299) were collected in a RCT comparing safety and efficacy of inhaled vs. injectable insulin. Validation examined item and factor characteristics, reliability and validity. Regression analyses examined relationships between overall and domain specific TS and the broader influences.

Results

Patients with less previous or current treatment burden had greater TS (p < 0.001). Gender, injection fear, functioning, age, compliance and glycemic control were differentially related to TS at the beginning and end of study. Baseline satisfaction was predictive of future TS (p < 0.001). When all significant factors were examined together, lower burden with the current treatment and higher satisfaction with previous treatment continued to be key (p < 0.001) while other factors were no longer significant. Validation findings confirmed the ITSQ was psychometrically sound.

Conclusion

Over the course of treatment, some factors are associated with TS at treatment start while others are key drivers at treatment end. This suggests that TS is not a static concept.
Literatuur
1.
go back to reference Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977–986.CrossRef Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977–986.CrossRef
2.
go back to reference UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837–853. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837–853.
3.
go back to reference Weaver, M., Patrick, D. L., Markson, L. E., Martin, D., Frederic, I., & Berger, M. (1997). Issues in the measurement of satisfaction with treatment. American Journal of Managed Care, 3, 579–594.PubMed Weaver, M., Patrick, D. L., Markson, L. E., Martin, D., Frederic, I., & Berger, M. (1997). Issues in the measurement of satisfaction with treatment. American Journal of Managed Care, 3, 579–594.PubMed
4.
go back to reference Cappelleri, J. C., Gerber, R. A., Kourides, I. A., & Gelfand, R. A. (2000). Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care, 23, 1799–1803.PubMedCrossRef Cappelleri, J. C., Gerber, R. A., Kourides, I. A., & Gelfand, R. A. (2000). Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care, 23, 1799–1803.PubMedCrossRef
5.
go back to reference Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care, 25, 458–463.PubMedCrossRef Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care, 25, 458–463.PubMedCrossRef
6.
go back to reference Taylor, M. D., Frier, B. M., Gold, A. E., & Beary, I. J. (2003). Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: the Edinburgh prospective diabetes study. Diabetes Medicine, 20, 135–146.CrossRef Taylor, M. D., Frier, B. M., Gold, A. E., & Beary, I. J. (2003). Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: the Edinburgh prospective diabetes study. Diabetes Medicine, 20, 135–146.CrossRef
7.
go back to reference Ahlgren, S. S., Shultz, J. A., Massey, L. K., Hicks, B. C., & Wysham, C. (2004) Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Quality of Life Research, 13, 819–832.PubMedCrossRef Ahlgren, S. S., Shultz, J. A., Massey, L. K., Hicks, B. C., & Wysham, C. (2004) Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Quality of Life Research, 13, 819–832.PubMedCrossRef
8.
go back to reference Anderson, R. T., Skovlund, S. E., Marrero, D., Levine, D. W., Meadows, K., Brod, M., & Balkrishnan, R. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26, 565–578.PubMedCrossRef Anderson, R. T., Skovlund, S. E., Marrero, D., Levine, D. W., Meadows, K., Brod, M., & Balkrishnan, R. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26, 565–578.PubMedCrossRef
9.
go back to reference Royle, P., Waugh, N., McAuley, L., McIntyre, L., & Thomas, S. (2003). Inhaled insulin in diabetes mellitus. The Cochrane Database of Systematic Reviews. Issue 4. Art. No.: CD003890.pub.2. Royle, P., Waugh, N., McAuley, L., McIntyre, L., & Thomas, S. (2003). Inhaled insulin in diabetes mellitus. The Cochrane Database of Systematic Reviews. Issue 4. Art. No.: CD003890.pub.2.
10.
go back to reference Atkinson, M. J., Kumar, R., Cappelleri, J. C., & Hass, S. L. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version ll) among outpatient pharmacy consumers. Value in Health, 8(1), 9–24.CrossRef Atkinson, M. J., Kumar, R., Cappelleri, J. C., & Hass, S. L. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version ll) among outpatient pharmacy consumers. Value in Health, 8(1), 9–24.CrossRef
11.
go back to reference Dunbar-Jacob, J., & Mortimer-Stephens, M. K. (2001). Treatment adherence in chronic disease. Journal of Clinical Epidemiology, 54 (Suppl 1), S57–S60 (Review). Dunbar-Jacob, J., & Mortimer-Stephens, M. K. (2001). Treatment adherence in chronic disease. Journal of Clinical Epidemiology, 54 (Suppl 1), S57–S60 (Review).
12.
go back to reference Robiner, W. N. (2005). Enhancing adherence in clinical research. Contemporary Clinical Trials, 26(1), 59–77 (Review). Robiner, W. N. (2005). Enhancing adherence in clinical research. Contemporary Clinical Trials, 26(1), 59–77 (Review).
13.
go back to reference Piette, J. D., Wagner, T. H., & Potter, M. B., et al. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42(2), 102–109.PubMedCrossRef Piette, J. D., Wagner, T. H., & Potter, M. B., et al. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42(2), 102–109.PubMedCrossRef
14.
go back to reference Haynes, R. B., McKibbon, K. A., & Kanani, R. (1996). Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348(9024), 383–386.PubMedCrossRef Haynes, R. B., McKibbon, K. A., & Kanani, R. (1996). Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348(9024), 383–386.PubMedCrossRef
15.
go back to reference Leo, R. J., Jassal, K., & Badhai, Y. D. (2005). Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry, 12(6), 33–39. Leo, R. J., Jassal, K., & Badhai, Y. D. (2005). Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry, 12(6), 33–39.
16.
go back to reference Gerber, R. A, Cappelleri, J. C, Kourides, I. A., & Gelfand, R. A. (2001). Treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Diabetes Care, 24, 1556–1559.PubMedCrossRef Gerber, R. A, Cappelleri, J. C, Kourides, I. A., & Gelfand, R. A. (2001). Treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Diabetes Care, 24, 1556–1559.PubMedCrossRef
17.
go back to reference Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J., & Levin, S. R. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care, 27, 2356–2362.PubMedCrossRef Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J., & Levin, S. R. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care, 27, 2356–2362.PubMedCrossRef
18.
go back to reference Quattrin, T., Belanger, A., Bohannon, N. J. V., & Schwartz, S. L. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes. Diabetes Care, 27, 2622–2627.PubMedCrossRef Quattrin, T., Belanger, A., Bohannon, N. J. V., & Schwartz, S. L. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes. Diabetes Care, 27, 2622–2627.PubMedCrossRef
19.
go back to reference Rosenstock, J., Cappelleri, J. C., Bolinder, B., & Gerber, R. A. (2004). Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care, 27, 1318–1323.PubMedCrossRef Rosenstock, J., Cappelleri, J. C., Bolinder, B., & Gerber, R. A. (2004). Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care, 27, 1318–1323.PubMedCrossRef
20.
go back to reference Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill J. B., Peterson, G. E., Mudaliar, S. R., & Reinhardt, R. R. (2003). Continuous subcutaneous insulin infusion and multiple daily injection therapy and equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care, 26, 2598–2603.PubMedCrossRef Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill J. B., Peterson, G. E., Mudaliar, S. R., & Reinhardt, R. R. (2003). Continuous subcutaneous insulin infusion and multiple daily injection therapy and equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care, 26, 2598–2603.PubMedCrossRef
21.
go back to reference Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., Lilos, P., Dickerman, Z., & Phillip, M. (2002). Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics, 112, 559–564.CrossRef Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., Lilos, P., Dickerman, Z., & Phillip, M. (2002). Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics, 112, 559–564.CrossRef
22.
go back to reference Bott, U., Ebrahim, S., Hirchberger, S., & Skovlund, S. E. (2003). Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetes Medicine, 20, 626–634.CrossRef Bott, U., Ebrahim, S., Hirchberger, S., & Skovlund, S. E. (2003). Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetes Medicine, 20, 626–634.CrossRef
23.
go back to reference Renner, R., Pfutzner, A., Trautmann, M., Harzer, O., Sauter, K., & Landgraf, R. (1999). Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care, 22, 784–788.PubMedCrossRef Renner, R., Pfutzner, A., Trautmann, M., Harzer, O., Sauter, K., & Landgraf, R. (1999). Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care, 22, 784–788.PubMedCrossRef
24.
go back to reference DeVries J. H., Snoek, F. J., Kostense, P. J., Masurel, N., & Heine, R. J. (2002). A randomized trial of continuous subcutaneous insulin infrion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care, 25, 2074–2080.PubMedCrossRef DeVries J. H., Snoek, F. J., Kostense, P. J., Masurel, N., & Heine, R. J. (2002). A randomized trial of continuous subcutaneous insulin infrion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care, 25, 2074–2080.PubMedCrossRef
25.
go back to reference Herman, W. H., Ilag, L. L., Johnson, S. L., Martin, C. L., Sinding, J., Al Harthi, A., Plunkett, C. D., LaPorte F. B., Burke, R., Brown, M. B., Halter, J. B., & Raskin, P. (2005). A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care, 28, 1568–1573.PubMedCrossRef Herman, W. H., Ilag, L. L., Johnson, S. L., Martin, C. L., Sinding, J., Al Harthi, A., Plunkett, C. D., LaPorte F. B., Burke, R., Brown, M. B., Halter, J. B., & Raskin, P. (2005). A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care, 28, 1568–1573.PubMedCrossRef
26.
go back to reference Janssen, M. M. J., Snoek, F. J., Masurel, N., Hoogma, R. P. L. M., Deville, W. L., Popp-Snijders, C., & Heine, R. J. (2000). Optimized based-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients. Diabetes Care, 23, 629–633.PubMedCrossRef Janssen, M. M. J., Snoek, F. J., Masurel, N., Hoogma, R. P. L. M., Deville, W. L., Popp-Snijders, C., & Heine, R. J. (2000). Optimized based-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients. Diabetes Care, 23, 629–633.PubMedCrossRef
27.
go back to reference Bech, P., Moses, R., & Gomis, R. (2003). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicenter study. Quality of Life Research, 12, 413–425.PubMedCrossRef Bech, P., Moses, R., & Gomis, R. (2003). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicenter study. Quality of Life Research, 12, 413–425.PubMedCrossRef
28.
go back to reference Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Brod, M., & Rowland, C. (2004). Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2, 12–25.PubMedCrossRef Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Brod, M., & Rowland, C. (2004). Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2, 12–25.PubMedCrossRef
29.
go back to reference Moses, R., Clauson, P., Vesterager, A., Roberts, A., & Wollmer, P. (2006). Inhaled preprandial human insulin (AERx iDMS) versus subcutaneous insulin aspart in type 1 diabetes. Poster presentation IDF, Cape Town, South Africa. Moses, R., Clauson, P., Vesterager, A., Roberts, A., & Wollmer, P. (2006). Inhaled preprandial human insulin (AERx iDMS) versus subcutaneous insulin aspart in type 1 diabetes. Poster presentation IDF, Cape Town, South Africa.
30.
go back to reference Snoek, F. J., Mollema, E. D., Heine, R. J., Bouter, L. M., & van der Ploeg, H. M. (1997). Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): First findings. Diabetes Medicine, 14, 871–876.CrossRef Snoek, F. J., Mollema, E. D., Heine, R. J., Bouter, L. M., & van der Ploeg, H. M. (1997). Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): First findings. Diabetes Medicine, 14, 871–876.CrossRef
31.
go back to reference Mollema, E., Snoek, F., Pouwer, F., Heine, R., & Van Der Ploeg, H. (2000). Diabetes fear of injecting and self-testing questionnaire. Diabetes Care, 23(6), 765–769. Mollema, E., Snoek, F., Pouwer, F., Heine, R., & Van Der Ploeg, H. (2000). Diabetes fear of injecting and self-testing questionnaire. Diabetes Care, 23(6), 765–769.
32.
go back to reference Kramer, J. (2006). The diabetes medication compliance scale (DMCS), measure under development. Kramer, J. (2006). The diabetes medication compliance scale (DMCS), measure under development.
33.
go back to reference Anderson, R., Skovlund, S. E., Marrero, D., & Schwartz, S. (2003). Self-reported non-adherence with insulin injection therapy in people with type 1 and 2 diabetes. Poster presentation IDF, Paris, France. Anderson, R., Skovlund, S. E., Marrero, D., & Schwartz, S. (2003). Self-reported non-adherence with insulin injection therapy in people with type 1 and 2 diabetes. Poster presentation IDF, Paris, France.
34.
go back to reference Welch, G. W., Weinger, K., Anderson, B., & Polonsky, W. H. (2003). Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabetic Medicine, 20, 69–72.PubMedCrossRef Welch, G. W., Weinger, K., Anderson, B., & Polonsky, W. H. (2003). Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabetic Medicine, 20, 69–72.PubMedCrossRef
35.
go back to reference Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997). The problem areas in diabetes scale: An evaluation of its clinical utility. Diabetes Care, 20, 760–766.PubMedCrossRef Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997). The problem areas in diabetes scale: An evaluation of its clinical utility. Diabetes Care, 20, 760–766.PubMedCrossRef
36.
go back to reference Ware, J. Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medicine Care, 34, 220–233.CrossRef Ware, J. Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medicine Care, 34, 220–233.CrossRef
37.
go back to reference Turner-Bowker, D. M., Bartley, P. J., & Ware, J. E. Jr. (2002). SF-36® health survey & “SF” bibliography: Third edition (1988–2000). Lincoln, RI: QualityMetric Incorporated. Turner-Bowker, D. M., Bartley, P. J., & Ware, J. E. Jr. (2002). SF-36® health survey & “SF” bibliography: Third edition (1988–2000). Lincoln, RI: QualityMetric Incorporated.
38.
go back to reference Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric, Incorporated. Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric, Incorporated.
39.
go back to reference Cronbach, L. F. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef Cronbach, L. F. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef
40.
go back to reference Scientific Advisory Committee of the Medical Outcomes Trust (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–205.CrossRef Scientific Advisory Committee of the Medical Outcomes Trust (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–205.CrossRef
41.
go back to reference Brod, M., Skovlund, S. E., & Wittrup-Jensen, K. (2006). Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research, 15, 481–491.PubMedCrossRef Brod, M., Skovlund, S. E., & Wittrup-Jensen, K. (2006). Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research, 15, 481–491.PubMedCrossRef
42.
go back to reference Brod, M., Mendelson, G., & Roberts, B. (1998). Patient’s experience of Parkinson’s disease. Journal of Gerontology, 53B(4), 213–222. Brod, M., Mendelson, G., & Roberts, B. (1998). Patient’s experience of Parkinson’s disease. Journal of Gerontology, 53B(4), 213–222.
Metagegevens
Titel
Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes
Auteurs
Meryl Brod
Torsten Christensen
Donald Bushnell
Publicatiedatum
01-08-2007
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 6/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9209-1

Andere artikelen Uitgave 6/2007

Quality of Life Research 6/2007 Naar de uitgave